Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Traboulsee, Anthony, Greenberg, Benjamin M, Bennett, Jeffrey L, Szczechowski, Lech, Fox, Edward, Shkrobot, Svitlana, Yamamura, Takashi, Terada, Yusuke, Kawata, Yuichi, Wright, Padraig, Gianella-BorradVolume:
19
Journal:
The Lancet Neurology
DOI:
10.1016/S1474-4422(20)30078-8
Date:
May, 2020
File:
PDF, 779 KB
2020